Ophthalmology – Wyburn–Mason Syndrome

What the Disorder Represents

Wyburn–Mason syndrome is a rare congenital, usually sporadic neuro-oculo-cutaneous vascular malformation syndrome characterized by arteriovenous malformations (AVMs) involving the retina and, in many affected patients, the ipsilateral brain, orbit, or facial structures.

It is also called:

• Bonnet–Dechaume–Blanc syndrome
• Retinocephalic vascular malformation syndrome
• Racemose hemangiomatosis

The characteristic ocular lesion is a:

Retinal arteriovenous malformation with direct communication between arteries and veins.

An Important Modern Distinction

An isolated retinal AVM is not automatically equivalent to Wyburn–Mason syndrome.

The term Wyburn–Mason syndrome is most appropriately used when retinal AVMs occur as part of a broader ipsilateral vascular malformation involving structures such as:

• Brain
• Orbit
• Face
• Maxillofacial tissues

A patient with a retinal racemose AVM should therefore be evaluated for:

Associated intracranial and orbital vascular malformations.

How the Vascular Malformation Develops

AVMs arise from abnormal embryologic vascular development.

Instead of normal progression:

Artery → arteriole → capillary bed → venule → vein

there is an abnormal direct connection between:

Arterial and venous circulations.

This creates a high-flow vascular shunt.

Why the Vessels Become So Dilated

Without the resistance of a normal capillary bed:

• Arterial blood enters veins at high pressure
• Feeding arteries enlarge
• Draining veins become dilated and tortuous
• High-flow shunting may develop

The retinal lesion therefore often looks like:

A striking tangle of enormously dilated arteries and veins with direct arteriovenous communication.

Genetic Pattern

Wyburn–Mason syndrome is generally:

Sporadic and nonhereditary.

No consistent Mendelian inheritance pattern has been established.

Routine family screening is therefore usually unnecessary unless another inherited vascular disorder is suspected.

Typical Laterality

The disorder is usually:

Unilateral

and associated CNS or facial vascular malformations tend to occur on the:

Same side as the retinal lesion.

Bilateral retinal involvement is unusual.

When It Becomes Apparent

The malformation is congenital, but diagnosis can occur at almost any age.

Some patients are detected:

• Incidentally during routine eye examination
• During evaluation for reduced vision
• After neurologic symptoms
• Following intracranial hemorrhage

Thus congenital disease does not necessarily mean:

Childhood presentation.

What Patients May Notice

Many patients with retinal AVMs remain asymptomatic.

Possible ocular symptoms include:

• Reduced visual acuity
• Visual-field loss
• Diplopia
• Eye redness
• Floaters
• Proptosis
• Ocular discomfort

Visual symptoms depend mainly on:

• Macular involvement
• Optic nerve involvement
• Vascular complications

Neurologic Symptoms

Associated intracranial AVMs may produce:

• Headache
• Seizures
• Focal weakness
• Sensory deficits
• Cranial nerve palsies
• Visual-field loss
• Altered consciousness

The most serious presentation is:

Intracranial hemorrhage.

Craniofacial Manifestations

Associated vascular malformations may involve:

• Orbit
• Conjunctiva
• Eyelids
• Face
• Maxilla
• Mandible
• Oral cavity

Possible findings include:

• Facial vascular lesions
• Dilated conjunctival vessels
• Epistaxis
• Oral bleeding
• Proptosis

Significant oral or maxillofacial AVMs can produce severe hemorrhage after:

Dental extraction or surgery.

The Classic Retinal Appearance

Fundus examination may show:

• Markedly dilated retinal arteries
• Markedly dilated retinal veins
• Tortuous vessels
• Direct artery-to-vein communications
• Little or no intervening normal capillary network

The vessels may involve:

• A limited retinal sector
• An entire retinal quadrant
• Much of the retina
• Optic nerve head

Traditional Retinal AVM Classification

The classic Archer classification divides retinal AVMs into three groups.

Group 1 – Mild AV Communication

There is an abnormal vascular network between artery and vein with a relatively recognizable intervening capillary component.

These lesions are generally:

• Less extensive
• Less visually destructive
• Less strongly associated with CNS AVMs

They may sometimes represent an isolated retinal vascular malformation rather than full Wyburn–Mason syndrome.

Group 2 – Direct Arteriovenous Communication

There is:

Direct communication between a retinal artery and vein without a normal intervening capillary bed.

The involved vessels are:

• Enlarged
• Tortuous
• High-flow

This pattern has a stronger association with:

Ipsilateral intracranial AVMs.

Group 3 – Extensive Racemose Malformation

This is the most dramatic phenotype.

Features include:

• Massive dilation of arteries and veins
• Numerous direct AV communications
• Extensive retinal involvement
• Difficulty distinguishing artery from vein

These eyes carry the greatest risk of:

• Poor vision
• Vascular occlusion
• Glaucoma
• Optic nerve damage

They are also more strongly associated with:

CNS involvement.

Optic Nerve Involvement

AVMs may involve or surround the optic disc.

Possible consequences include:

• Optic disc edema
• Optic atrophy
• Reduced color vision
• RAPD when asymmetric
• Visual-field loss

Vision may be limited from birth or deteriorate later because of vascular complications.

Why Vision May Be Poor Even Without Hemorrhage

Reduced vision can result from:

• Macular involvement by anomalous vessels
• Chronic retinal ischemia
• Optic nerve dysfunction
• Amblyopia in childhood
• Vascular occlusion
• Secondary glaucoma

Therefore visual loss is not necessarily due to bleeding.

Fluorescein Angiography

FA classically demonstrates:

Very rapid arteriovenous transit through the abnormal communications.

Typical findings include:

• Early arterial filling
• Almost immediate filling of draining veins
• Enlarged feeding and draining vessels

Unlike retinal neovascularization, uncomplicated AVMs generally show:

Little or no leakage.

Why the Lack of Leakage Matters

The absence of substantial fluorescein leakage helps distinguish congenital AVMs from:

• Proliferative diabetic retinopathy
• Retinal neovascularization
• Vasoproliferative tumors

Leakage may occur if secondary vascular complications develop.

Optical Coherence Tomography

OCT can demonstrate:

• Enlarged intraretinal vascular channels
• Shadowing beneath abnormal vessels
• Distortion of retinal layers
• Macular edema if complications develop

OCT is most useful when the AVM approaches:

The macula or optic nerve.

OCT Angiography

OCTA can noninvasively demonstrate:

• Abnormal high-flow retinal vessels
• Direct arteriovenous channels
• Distortion of superficial and deep vascular plexuses

It is useful for structural vascular mapping but does not replace angiographic or neurovascular imaging when associated cerebral AVMs are suspected.

Why Brain Imaging Is Essential

A patient with a retinal AVM suggestive of Wyburn–Mason syndrome should undergo evaluation for:

Intracranial and orbital AVMs.

Initial imaging usually includes:

• MRI of the brain and orbits
• MRA

CTA may be used in selected circumstances.

Role of Catheter Cerebral Angiography

Digital subtraction angiography provides the most detailed assessment of:

• Feeding arteries
• Nidus architecture
• Venous drainage
• High-risk aneurysms

It is not required for every incidental retinal AVM.

It is generally reserved when:

• MRI/MRA identifies an intracranial AVM
• Treatment is being considered
• Detailed neurovascular anatomy is required

Why Neurology or Neurosurgery Referral Matters

Retinal AVMs can be the first visible sign of a clinically silent:

Cerebral AVM.

Identification of a retinal racemose malformation therefore warrants neurovascular evaluation even when the patient has:

No neurologic symptoms.

Important Ocular Complications

Although many retinal AVMs remain stable, complications can include:

• Retinal vein occlusion
• Retinal ischemia
• Macular edema
• Retinal hemorrhage
• Vitreous hemorrhage
• Secondary neovascularization
• Secondary glaucoma
• Optic neuropathy

Retinal Vascular Occlusion

Abnormal hemodynamics may predispose to:

• Branch retinal vein occlusion
• Central retinal vein occlusion
• Less commonly arterial compromise

Occlusion may produce:

• Retinal hemorrhage
• Macular edema
• Ischemia
• Neovascularization

Neovascular Glaucoma

Extensive retinal ischemia after vascular occlusion may produce:

VEGF-driven iris and angle neovascularization.

This may lead to:

Neovascular glaucoma.

Treatment requires management of both:

• Retinal ischemia
• Elevated IOP

Glaucoma From Elevated Episcleral Venous Pressure

A second glaucoma mechanism can occur when orbital or episcleral AV communications raise:

Episcleral venous pressure.

Clinical clues include:

• Dilated episcleral vessels
• Elevated IOP
• Open angle
• Blood in Schlemm canal on gonioscopy in some cases

This mechanism differs from neovascular glaucoma.

Why the Glaucoma Mechanism Must Be Identified

Management differs substantially between:

Ischemic neovascular glaucoma

Requires suppression of retinal VEGF drive.

Elevated episcleral venous pressure

Results from impaired aqueous drainage against an abnormally high venous pressure.

Gonioscopy and retinal examination are therefore essential.

Treating Elevated IOP

Medical treatment may include:

• Topical beta-blocker
• Carbonic anhydrase inhibitor
• Alpha-2 agonist
• Prostaglandin analogue

Systemic acetazolamide may be used when stronger short-term IOP lowering is needed.

Role of Miotics

Older references listed miotics among routine glaucoma therapies.

They are not particularly useful for the typical mechanisms of glaucoma in Wyburn–Mason syndrome and are:

Not a preferred modern first-line strategy.

Treatment should be based on the actual glaucoma mechanism.

Treating Neovascular Complications

When retinal ischemia produces neovascularization:

• Panretinal photocoagulation (PRP) may be indicated
• Intravitreal anti-VEGF can provide rapid temporary regression of neovascularization

Anti-VEGF is an adjunct because:

The underlying ischemic retina remains the definitive treatment target.

Important Correction About Laser Treatment

The congenital retinal AVM itself is generally:

Not treated with destructive laser simply because it is present.

Direct photocoagulation of a high-flow retinal AVM can be hazardous and is rarely appropriate.

Laser is primarily directed at:

Secondary ischemic or neovascular complications.

Vitreous Hemorrhage

Nonclearing vitreous hemorrhage may require:

Pars plana vitrectomy

especially if:

• Vision remains substantially reduced
• Retinal traction is present
• Retinal pathology cannot otherwise be monitored

Amblyopia

Children with unilateral visual impairment may develop:

Amblyopia.

When appropriate, management may include:

• Optical correction
• Patching
• Atropine penalization in selected cases

However, amblyopia treatment can only improve the portion of vision loss attributable to abnormal visual development, not structural retinal damage.

Strabismus

Strabismus may occur from:

• Poor unilateral vision
• Cranial nerve dysfunction
• Orbital involvement

Management depends on:

• Visual potential
• Stability
• Neurologic status

Surgery can be considered when appropriate.

Management of the Retinal AVM Itself

For an uncomplicated retinal AVM:

Observation is usually the preferred strategy.

Follow with:

• Visual acuity
• IOP
• Dilated fundus examination
• Photography
• OCT when useful

Treatment is reserved for:

Complications rather than the vascular anomaly itself.

Does the AVM Spontaneously Disappear?

True spontaneous involution is:

Uncommon and should not be expected.

Most congenital retinal AVMs are structurally persistent, although their appearance and complications may remain stable for long periods.

Treatment of Intracranial AVMs

Management of a cerebral AVM is highly individualized.

Options can include:

• Observation
• Endovascular embolization
• Microsurgical resection
• Stereotactic radiosurgery
• Multimodal treatment

The decision depends on:

• AVM size
• Location
• Venous drainage
• Previous hemorrhage
• Neurologic symptoms
• Treatment risk

Why Not Every Brain AVM Is Treated

Intervention itself can cause:

• Stroke
• Hemorrhage
• Neurologic deficit
• Death

Therefore neurosurgical management requires careful comparison of:

Natural-history risk vs treatment risk.

Retinal AVM presence alone is not an automatic indication for brain AVM intervention.

Oral and Maxillofacial Precautions

If facial, mandibular, or oral AVMs are present, apparently routine procedures such as:

• Dental extraction
• Biopsy
• Oral surgery

can provoke:

Severe hemorrhage.

Relevant vascular imaging should precede invasive procedures when a significant maxillofacial AVM is suspected.

Key Diagnostic Alternatives

Important differentials include:

• Congenital retinal macrovessel
• Retinal cavernous hemangioma
• Retinal capillary hemangioblastoma
• Vasoproliferative retinal tumor
• Retinal telangiectasia
• Retinal collaterals
• Intraretinal microvascular abnormalities
• Sturge-Weber syndrome

Wyburn–Mason vs Von Hippel-Lindau Disease

Wyburn–Mason

• Direct retinal artery-vein communications
• Markedly dilated racemose vessels
• Usually unilateral
• Associated with CNS AVMs
• No discrete vascular tumor required

VHL

• Retinal capillary hemangioblastoma
• Orange-red tumor mass
• Prominent feeding arteriole and draining venule
• Often multiple/bilateral
• Associated with RCC, CNS hemangioblastoma, pheochromocytoma, etc.

Wyburn–Mason vs Retinal Cavernous Hemangioma

Retinal cavernous hemangioma consists of:

• Clusters of thin-walled venous aneurysms
• “Bunch of grapes” appearance
• Slow blood flow
• Plasma-erythrocyte layering

This is very different from the:

High-flow artery-to-vein shunting of Wyburn–Mason syndrome.

Wyburn–Mason vs Sturge-Weber Syndrome

Sturge-Weber syndrome classically involves:

• Port-wine birthmark
• Leptomeningeal capillary-venous malformation
• Diffuse choroidal hemangioma
• Glaucoma

Wyburn–Mason instead features:

True high-flow arteriovenous malformations of the retina and CNS.

Wyburn–Mason vs Congenital Retinal Macrovessel

A congenital retinal macrovessel is usually:

• A single anomalous large retinal vessel
• Often crossing the horizontal raphe
• Frequently incidental

It does not usually produce the extensive direct arteriovenous shunting seen in:

Racemose retinal AVMs.

Long-Term Monitoring

Patients should receive periodic:

Ophthalmic surveillance

for:

• Vision
• IOP
• Retinal vascular complications
• New hemorrhage
• Neovascularization

Neurologic follow-up depends on the presence and anatomy of associated CNS disease.

When Urgent Assessment Is Needed

Patients require urgent evaluation for:

• Sudden severe headache
• New neurologic deficit
• Seizure
• Altered consciousness
• Sudden visual loss
• Painful red eye with elevated IOP
• Vitreous hemorrhage

These may represent:

• Intracranial hemorrhage
• Retinal vascular occlusion
• Neovascular glaucoma
• Other acute complications

Expected Ocular Course

Prognosis varies greatly.

A limited peripheral retinal AVM may remain stable with excellent vision.

More extensive lesions involving:

• Macula
• Optic nerve
• Major retinal circulation

can cause significant permanent visual impairment.

What Determines Neurologic Prognosis

Systemic prognosis depends principally on:

• Location and size of cerebral AVMs
• Previous intracranial hemorrhage
• Associated aneurysms
• Neurologic deficits
• Feasibility and risk of treatment

Some patients remain neurologically asymptomatic throughout life.

High-Yield Takeaways

• Wyburn–Mason syndrome is a rare, usually sporadic congenital disorder characterized by retinal AVMs associated with ipsilateral cerebral, orbital, or craniofacial AVMs.
• It is also called Bonnet–Dechaume–Blanc syndrome or retinocephalic vascular malformation syndrome.
• An isolated retinal AVM does not automatically establish Wyburn–Mason syndrome; associated CNS disease should be sought.
• Retinal AVMs consist of direct artery-to-vein communications with absent or reduced intervening capillary beds.
• The classic fundus appearance is massively dilated, tortuous arteries and veins with direct arteriovenous shunting.
• The traditional Archer classification includes Group 1 mild AV communication, Group 2 direct AV communication, and Group 3 extensive racemose malformation.
• More extensive Group 2 and 3 lesions have a stronger association with intracranial AVMs.
• FA classically shows rapid arteriovenous transit with little leakage in uncomplicated lesions.
• OCT and OCTA can document retinal structural distortion and abnormal vascular channels.
• Discovery of a significant retinal AVM should prompt brain/orbital MRI and vascular imaging, usually MRI/MRA initially.
• Catheter cerebral angiography is reserved for selected patients when an intracranial AVM requires detailed characterization or treatment planning.
• The retinal AVM itself is usually observed rather than directly treated.
• Important ocular complications include retinal vein occlusion, retinal ischemia, vitreous hemorrhage, macular edema, neovascularization, and glaucoma.
• Glaucoma may arise from either retinal ischemia causing neovascular glaucoma or elevated episcleral venous pressure from orbital AV shunting.
• PRP and anti-VEGF are used for secondary ischemic neovascular complications, not routinely to eradicate the congenital AVM.
• Vitrectomy may be required for nonclearing vitreous hemorrhage or tractional complications.
• Severe oral or maxillofacial AVMs may produce dangerous hemorrhage during dental or surgical procedures.
• Cerebral AVM management may involve observation, embolization, microsurgery, stereotactic radiosurgery, or combinations, depending on individualized hemorrhage and treatment risk.
• Wyburn–Mason is distinct from VHL, which produces retinal capillary hemangioblastomas, and from Sturge-Weber, which produces capillary-venous malformations and diffuse choroidal hemangioma.
• Patients require long-term ophthalmic and neurologic surveillance because complications can develop despite years of stability.

High-Yield Takeaways